ICD-10-CM Billable Code

N06.A

Isolated proteinuria with C3 glomerulonephritis

Clinical Classification Guidelines

Inclusion Terms

  • Isolated proteinuria with C3 glomerulopathy

Excludes Type 1

  • Isolated proteinuria (with C3 glomerulopathy) with dense deposit disease (N06.6)

Medical Intelligence & Overview

Isolated proteinuria with C3 glomerulonephritis is a kidney condition characterized by the presence of excess protein in the urine along with a specific type of inflammation affecting the tiny filters within the kidneys known as glomeruli. This condition falls under the broader category of C3 glomerulopathy, which involves abnormal immune system activity leading to kidney damage. Recognizing the signs and understanding the causes can help in managing and monitoring this condition effectively.

Causes & Symptoms

Clinical Causes: Dysregulation of the complement system, particularly involving C3, leading to immune-mediated damage. Genetic mutations affecting complement regulatory proteins. Underlying autoimmune disorders that activate the complement pathway. Infections that trigger immune responses damaging the kidneys. Unknown causes in some cases, indicating idiopathic origins.

Key Symptoms: Proteinuria: Excess protein in the urine, which might be detected through routine testing or when it causes foamy urine. Edema: Swelling in parts of the body such as the legs, ankles, or around the eyes due to fluid retention. Decreased kidney function, leading to elevated blood pressure or signs of waste buildup in the blood. Urinary abnormalities: Sometimes blood may be visible in the urine. Fatigue and general feeling of illness in advanced cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of tests and examinations to confirm the presence of proteinuria and assess kidney health: - Urinalysis: To detect protein and other abnormalities in the urine. - Blood tests: Measuring kidney function indicators like serum creatinine and blood urea nitrogen (BUN). - Imaging studies: Ultrasound scans to evaluate kidney size and structure. - Kidney biopsy: The definitive test, where a small tissue sample is examined microscopically for signs of C3 glomerulonephritis and immune deposits. - Complement levels: Blood tests to measure levels of complement proteins, especially C3, to identify abnormalities. The combination of these assessments helps in diagnosing isolated proteinuria with C3 glomerulonephritis and differentiating it from other kidney diseases.

Treatment Protocols: Management focuses on controlling the immune response and preserving kidney function: - Immunosuppressive medications: Corticosteroids and other agents to reduce inflammation. - Medications to control blood pressure: Such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), which also reduce proteinuria. - Plasma exchange therapy: In some cases, to remove abnormal immune components. - Regular monitoring: Ongoing assessment of kidney function and protein levels. - Lifestyle modifications: Including dietary changes and maintaining blood pressure within target ranges. - Experimental therapies: Ongoing research may offer additional options in the future. Treatment plans are tailored to individual patient needs and the severity of the condition, with a focus on slowing progression and preventing further kidney damage.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N06.A a billable ICD-10 code?
Yes, N06.A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N06.A?
Clinical documentation must specify the nature of Isolated proteinuria with C3 glomerulonephritis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

glomerulonephritis isolated proteinuria